Palvella Therapeutics, Inc.

PVLA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$17$19-$28-$46
Dep. & Amort.$0$0$0$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$0$0
Change in WC-$0-$3$2$31
Other Non-Cash$6-$30$11$5
Operating Cash Flow-$11-$14-$15-$8
Investing Activities
PP&E Inv.$0$0$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$1
Financing Activities
Debt Repay.$78$0$0$0
Stock Issued$0$0$0$59
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$9$5$10$0
Financing Cash Flow$87$5$10$59
Forex Effect$0$0$0-$3
Net Chg. in Cash$76-$9-$5$47
Supplemental Information
Beg. Cash$7$16$21$70
End Cash$84$7$16$118
Free Cash Flow-$11-$14-$15-$9
Palvella Therapeutics, Inc. (PVLA) Financial Statements & Key Stats | AlphaPilot